Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hubert Chen, MD
Amylin Pharmaceuticals, LLC.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Birmingham, Alabama, United States
- Research Site
Chandler, Arizona, United States
- Research Site
Santa Rosa, California, United States
- Research Site
Walnut Creek, California, United States
- Research Site
Denver, Colorado, United States
- Research Site
Jacksonville, Florida, United States
- Research Site
Miami, Florida, United States
- Research Site
Chicago, Illinois, United States
- Research Site
Overland Park, Kansas, United States
- Research Site
Baton Rouge, Louisiana, United States
- Research Site
Butte, Montana, United States
- Research Site
Cincinnati, Ohio, United States
- Research Site
Eugene, Oregon, United States
- Research Site
Medford, Oregon, United States
- Research Site
Greer, South Carolina, United States
- Research Site
Mt. Pleasant, South Carolina, United States
- Research Site
Austin, Texas, United States
- Research Site
Olympia, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2008
- Primary completion
- 30 Sept 2009
- Completion
- 30 Sept 2009
- Last update posted
- 19 Jan 2015
- Registered enrollment
- 273
- Registry id
- NCT00785408
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.